Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. In the past
ALL was intractable but now the survival probability is as high as 80–90%. Improved …

Thymic stromal lymphopoietin (TSLP) is a pleiotropic cytokine originally isolated from a
murine thymic stromal cell line. TSLP exerts its biological effects by binding to a high-affinity …

Philadelphia chromosome–like acute lymphoblastic leukemia (Ph-like ALL; BCR-ABL1–like
ALL) in children with National Cancer Institute (NCI) intermediate-or high-risk (HR) ALL is …

In childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL), cytogenetic
abnormalities remain important diagnostic and prognostic tools. A number of well …

Acute lymphoblastic leukaemia (ALL) is a prevalent form of pediatric cancer that accounts for
70–80% of all leukemias. Genome-based analysis, exome sequencing, transcriptomics and …

Background Embedding techniques for converting high-dimensional sparse data into low-
dimensional distributed representations have been gaining popularity in various fields of …

Chimeric antigen receptor (CAR) T-cell technology has seen a rapid development over the
last decade mostly due to the potential that these cells may have in treating malignant …

Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer and also occurs in
adults. Although the outcomes of multi-agent chemotherapy regimens have greatly …

Compared to younger and older age groups, the incidence of acute lymphoblastic leukemia
(ALL) and lymphoblastic lymphoma (LBL) has increased more in the adolescent and young …

Acute lymphoblastic leukemia (ALL) is a hematologic malignancy arising from precursors of
the lymphoid lineage. Conventional cytotoxic chemotherapies have resulted in high cure …